Kyiv (AFP) | 09/06/2025 - 14:03:03 | Zelensky says next rounds of prisoner exchange with Russia over 'coming days'
Moscow (AFP) | 09/06/2025 - 13:53:04 | Russia says first stage of prisoner exchange with Ukraine completed
London (AFP) | 09/06/2025 - 13:15:10 | UK govt U-turns on scrapping pensioners' heating benefit
Moscow (AFP) | 09/06/2025 - 11:59:34 | Russia slams NATO 'aggression' over air defence spending call
Paris (AFP) | 09/06/2025 - 11:51:15 | France to seek 'swift return' of citizens aboard Gaza-bound boat intercepted by Israel
San Francisco (AFP) | 09/06/2025 - 11:39:29 | 60 people arrested in San Francisco in anti-ICE raids protests: police
Nice (AFP) | 09/06/2025 - 11:28:44 | Brazil's Lula slams 'threat of unilateralism' to oceans
Beijing (AFP) | 09/06/2025 - 11:27:39 | China tells citizens in LA to boost personal security over unrest
Istanbul (AFP) | 09/06/2025 - 10:46:53 | Turkey slams Israel for intercepting Gaza-bound aid boat
Nice (AFP) | 09/06/2025 - 10:25:38 | World must not let deep sea become 'wild west': Guterres
By Phil Chetwynd, AFP Global News Director
The Israel-Hamas war is one of the most complex and divisive stories AFP has covered. It touches historical fault lines that are generating visceral emotions in our societies, and in our newsrooms.
RevBio, Inc., announced that it has received approval from the Medicines and Health Regulatory Agency (MHRA) to conduct a 15 patient pilot clinical trial to use TETRANITE® to reintegrate bone flaps, which are portions of the skull that are temporarily removed by neurosurgeons to perform brain surgery. This clinical trial is designed to demonstrate that TETRANITE can reintegrate these bone flaps with the surrounding bone to improve cosmesis, increase flap stability for patient comfort, and help ...
